In the early stages of T2DM, the reduced secretory function of β-cells causes a decrease in insulin and amylin levels, which is an important mechanism, leading to IR and dysregulation of glucose metabolism [32]. The gene discussed is IAPP; the disease is type 2 diabetes mellitus.